AAWH (Ascend Wellness Holdings) YoY EBITDA Growth: 54.02% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AAWH Ascend Wellness Holdings Inc AAWH
42 GF Score
Price $0.43
GF Value $0.64
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Ascend Wellness Holdings YoY EBITDA Growth?

Ascend Wellness Holdings AAWH +5.33% 42 YoY EBITDA Growth is 54.02% as of Jun. 2026. GuruFocus rates AAWH with a GF Score™ of 42/100 and a GF Value™ of $0.64 (Possible Value Trap). The stock has 6 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ascend Wellness Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2026 was 54.02%.

Ascend Wellness Holdings's EBITDA per Share for the three months ended in Jun. 2026 was $0.13.

Ascend Wellness Holdings YoY EBITDA Growth Related Terms

Ascend Wellness Holdings YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Ascend Wellness Holdings's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascend Wellness Holdings YoY EBITDA Growth Chart

Ascend Wellness Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
YoY EBITDA Growth
Get a 7-Day Free Trial -100.00 0.00 158.13 -22.28 -8.10

Ascend Wellness Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.54 77.78 -81.98 -0.93 54.02
AAWH
42GF Score
Ascend Wellness Holdings Inc AAWH
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascend Wellness Holdings YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ascend Wellness Holdings's YoY EBITDA Growth for the fiscal year that ended in Dec. 2025 is calculated as:

YoY EBITDA Growth (A: Dec. 2025 )
=(EBITDA per Share (A: Dec. 2025 )-EBITDA per Share (A: Dec. 2024 ))/ | EBITDA per Share (A: Dec. 2024 ) |
=(0.295-0.321)/ | 0.321 |
=-8.10 %

Ascend Wellness Holdings's YoY EBITDA Growth for the quarter that ended in Jun. 2026 is calculated as:

YoY EBITDA Growth (Q: Jun. 2026 )
=(EBITDA per Share (Q: Jun. 2026 )-EBITDA per Share (Q: Jun. 2025 )) / | EBITDA per Share (Q: Jun. 2025 )) |
=(0.134-0.087)/ | 0.087 |
=54.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of 54.02% mean?
Ascend Wellness Holdings (AAWH) has a YoY EBITDA Growth of 54.02% as of Jun. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ascend Wellness Holdings and its competitors.
Is Ascend Wellness Holdings' YoY EBITDA Growth too high?
Ascend Wellness Holdings' current YoY EBITDA Growth is 54.02%. Overall, Ascend Wellness Holdings has a GF Score™ of 42/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ascend Wellness Holdings' YoY EBITDA Growth compare to ZTS?
Ascend Wellness Holdings' YoY EBITDA Growth of 54.02% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Drug Manufacturers company?
A good YoY EBITDA Growth depends on the Drug Manufacturers industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Ascend Wellness Holdings and its competitors. Ascend Wellness Holdings's current YoY EBITDA Growth is 54.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascend Wellness Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ascend Wellness Holdings (AAWH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.64, compared to a current price of $0.43 — trading 32.7% below its estimated fair value. The current YoY EBITDA Growth is 54.02%. Ascend Wellness Holdings' overall GF Score™ is 42/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Ascend Wellness Holdings (AAWH), the current YoY EBITDA Growth is 54.02% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ascend Wellness Holdings (AAWH) Overvalued in 2026?

Based on GuruFocus' analysis, Ascend Wellness Holdings stock appears to be undervalued. The current stock price of $0.43 is trading 32.7% below its estimated GF Value™ of $0.64. GuruFocus considers Ascend Wellness Holdings to be Possible Value Trap.

Key valuation signals for AAWH:

  • YoY EBITDA Growth: 54.02%
  • GF Value™: $0.64 vs. price of $0.43 (32.7% below fair value)
  • GF Score™: 42/100 with 6 warning signs

No single metric tells the full story. See the AAWH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ascend Wellness Holdings Business Description

Other Exchanges 8VJ:GermanyAAWH.U:Canada
Address Rochelle Park, Morristown, NJ, USA, 07662
Ascend Wellness Holdings Inc is a vertically integrated multi-state operator focused on adult-use or near-term adult-use cannabis states in limited licenses markets. The company's core business is the cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which it sells through company-owned retail stores and third-party licensed cannabis retail stores. It generates maximum revenue from the retail product segment.
42GF Score

Get the complete analysis for AAWH

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.43
Price
$0.64
GF Value